.png){kind=logo}
Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Feb 24, 2023A second randomized controlled trial sponsored by JDRF also demonstrates superiority of automated insulin pump as first-in-line therapy for children with type 1 diabetesMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced one-year data from the ADAPT study (n=82), the first multi-national randomized controlled study comparing the...
- Feb 16, 2023
Medtronic plc, the global leader in medical technology, today announced its participation in the upcoming 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD)...
Dec 9, 2022Medtronic Canada is pleased to announce Health Canada has licensed the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days with Medtronic insulin...
- Nov 15, 2022Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day...
Nov 1, 2022The MiniMed 780G system is the only insulin pump that automatically adjusts and corrects every five minutes to help keep sugar levels in rangeMedtronic Canada is pleased to announce that it has received a license from Health Canada for its MiniMed™ 780G system for people living with type 1 diabetes. This system with advanced hybrid...
Oct 18, 2022Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's...
Sep 1, 2022First-of-its-kind study demonstrates individuals using the Medtronic system achieved 1.4% absolute reduction in A1c and 27.6% absolute increase in Time in RangeMedtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced results from the Medtronic ADAPT study were published in The Lancet Diabetes & Endocrinology. The ADAPT study is...
Sep 1, 2022Combination of InPen™ smart insulin pen system integrated with Guardian™ 4 CGM helps people with diabetes on multiple daily injections (MDI) stay ahead of their glucose levelsi,iiToday Medtronic announced the European launch of its Smart MDI system, which combines personalized insulin dosing information from the InPen™ smart insulin pen with the power of predictive...
Aug 3, 2022Former Disney Channel Actress Shares How the Medtronic InPen™ system Helps Her Balance Demands of Dual CareerActress Jennifer Stone, best known for her role on the Disney Channel’s “Wizards of Waverly Place”, will be partnering with Medtronic Diabetes to help others living with type 1 diabetes...
Jun 4, 2022This week, Medtronic is presenting new MiniMed™ 780G system real-world data from Europe and Chile and clinical data at the American Diabetes Association (ADA) 82nd Scientific Sessions. The...
- May 31, 2022Medtronic presence to include 1 3 data presentations, a LinkedIn Livestream featuring Que Dallara, EVP & President, Medtronic Diabetes, comprehensive exhibit booth with presentations and a product theatre
Medtronic plc, the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 82nd scientific sessions virtual meeting, June 3-7, 2022....
- Apr 27, 2022Results were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
Medtronic reported study results from the extended study phase of its MiniMed™ 780G system[i] pivotal trial with new data using its no-calibration, non-adjunctive Guardian™ 4 sensor[ii]. The...
- Apr 25, 2022
Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...
Apr 20, 2022Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for its advanced insulin delivery system, MiniMed 780G, has been recently expanded across two more...
Mar 14, 2022Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for continuous glucose monitoring (CGM), a key diabetes technology has been recently expanded or...
- Dec 22, 2021Medicare coverage for Medtronic customers will be available 60 days after official publication
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand Medicare coverage for all types of...
- Dec 15, 2021
Medtronic plc (NYSE:MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) on December 9 for the company's Northridge, California, facility, the...
- Oct 19, 2021Harder to manage pediatric and adolescent patients achieve 74% Time in Range, and 82% overnight Time in Range, well surpassing clinical consensus guidelines for glycemic control
Medtronic plc (NYSE: MDT), a leading global healthcare technology company, recently announced one-year, real-world clinical data on 3,211 pediatric and adolescent patients with type 1 diabetes 15...
- Jun 28, 2021Data Were Presented at the American Diabetes Association 81st Scientific Sessions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association Scientific Sessions. The...
- Jun 23, 2021Data Showcases the Company's Most Advanced Product Portfolio Designed to Meet Patients Where They Are In Their Diabetes Journey
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific sessions virtual meeting, June...
- Jun 2, 2021Results Demonstrate 76% Time in Range and 94% Time in Advanced Hybrid Closed Loop Mode
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 4,120 individuals on the MiniMed™ 780G system, a small subset of those on the...
- Jun 1, 2021Data on the Company's Holistic Portfolio Will Include Real-World Data on MiniMed™ 780G System and New Data on Medtronic Continuous Glucose Monitoring Systems and Extended-Wear Infusion Set
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its virtual participation at the 14th International Conference on Advanced Technologies & Treatments for Diabetes...
- May 26, 2021New No Fingerstick1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark for expanded functionality of the company's InPen™ smart2 insulin pen for...
Apr 14, 2021Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set that can...
- Apr 7, 2021New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diabetes. The company committed...